GYRE Gyre Therapeutics, Inc.
Gyre Therapeutics, Inc. (GYRE) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 9% planned / 91% discretionary
Largest single sale: $120.0K.
Where they traded
No open-market insider purchase on record.
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Ye Weiguo | Chief Operating Officer | Sell | 3,000 | $6.35 | $19.1K | 700,000 −0.4% of holding | |
| Ye Weiguo | Chief Operating Officer | Sell | 2,800 | $6.17 | $17.3K | 700,000 −0.4% of holding | |
| Ye Weiguo 2 fills | Chief Operating Officer | Sell | 11,418 | $6.22 | $71.1K | 700,000 −1.6% of holding | |
| Ye Weiguo 2 fills | Chief Operating Officer | Sell | 17,500 | $6.14 | $107.5K | 700,000 −2.4% of holding | |
| Ye Weiguo | Chief Operating Officer | Sell | 15,401 | $6.40 | $98.6K | 700,000 −2.2% of holding | |
| Ye Weiguo | Chief Operating Officer | Sell | 19,575 | $6.13 | $120.0K | 700,000 −2.7% of holding | |
| Ye Weiguo | Chief Operating Officer | Sell | 4,000 | $6.10 | $24.4K | 700,000 −0.6% of holding | |
| Ye Weiguo | Chief Operating Officer | Sell | 3,500 | $6.08 | $21.3K | 700,000 −0.5% of holding | |
| Ye Weiguo | Chief Operating Officer | Sell | 12,820 | $6.15 | $78.8K | 700,000 −1.8% of holding | |
| Ye Weiguo | Chief Operating Officer | Sell | 9,400 | $6.15 | $57.8K | 700,000 −1.3% of holding | |
| Ye Weiguo | Chief Operating Officer | Sell | 9,120 | $6.37 | $58.1K | 700,000 −1.3% of holding | |
| Ye Weiguo | Chief Operating Officer | Sell | 200 | $6.62 | $1.3K | 700,000 −0% of holding | |
| Ye Weiguo | Chief Operating Officer | Sell | 13,100 | $6.65 | $87.1K | 700,000 −1.8% of holding | |
| Ye Weiguo | Chief Operating Officer | Sell | 15,580 | $6.91 | $107.7K | 700,000 −2.2% of holding | |
| Luo Ying | Chief Executive Officer | Sell 10b5-1 | 10,136 | $8.04 | $81.5K | 2,565,226 −0.4% of holding | |
| Luo Ying | Chief Executive Officer | Sell 10b5-1 | 179 | $8.01 | $1.4K | 2,575,362 −0% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.